TransUnion (TRU) Sells TransUnion Healthcare to Clearlake Capital's nThrive for $1.7B
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
TransUnion Announces Agreement to Sell TransUnion Healthcare to Clearlake Capital Group-Backed nThrive for $1.7 Billion
October 26, 2021 6:22 AM EDTCHICAGO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) has signed a definitive agreement to sell TransUnion Healthcare, Inc. (TransUnion Healthcare) to nThrive, Inc. (nThrive), a leading healthcare revenue cycle management (RCM) software-as-a-service (SaaS) platform backed by Clearlake Capital Group, L.P. (together with certain affiliates, Clearlake).
The transaction consideration is $1.735 billion in cash, and the transaction is expected to result in approximately $1.4 billion in after-tax proceeds at current tax rates. The parties are targeting to close the transaction in the fourth quarter of 2021, subject to the satisfaction of customary closing conditions and regulatory approvals. The... More
